Study design comparing written exposure therapy to cognitive processing therapy for PTSD among military service members: A noninferiority trial

For the STRONG STAR Consortium

Research output: Contribution to journalArticle

Abstract

Although there are a number of effective treatments for posttraumatic stress disorder (PTSD), there is a need to develop more efficient evidence-based PTSD treatments to address barriers to seeking and receiving treatment. Written exposure therapy (WET) is a potential alternative that is a 5-session treatment without any between-session assignments. WET has demonstrated efficacy, and low treatment dropout rates. However, prior studies with WET have primarily focused on civilian samples. Identifying efficient PTSD treatments for military service members is critical given the high prevalence of PTSD in this population. The current ongoing randomized clinical trial builds upon the existing literature by investigating whether WET is equally efficacious as Cognitive Processing Therapy (CPT) in a sample of 150 active duty military service members diagnosed with PTSD who are randomly assigned to either WET (n = 75) or CPT (n = 75). Participants are assessed at baseline and 10, 20, and 30 weeks after the first treatment session. The primary outcome measure is PTSD symptom severity assessed with the Clinician Administered PTSD Scale for DSM-5. Given the prevalence of PTSD and the aforementioned limitations of currently available first-line PTSD treatments, the identification of a brief, efficacious treatment that is associated with reduced patient dropout would represent a significant public health development.

Original languageEnglish (US)
Article number100507
JournalContemporary Clinical Trials Communications
Volume17
DOIs
StatePublished - Mar 2020

Fingerprint

Implosive Therapy
Cognitive Therapy
Post-Traumatic Stress Disorders
Patient Dropouts
Randomized Controlled Trials
Public Health
Outcome Assessment (Health Care)

Keywords

  • Clinical trial
  • Cognitive behavioral therapy
  • Posttraumatic stress disorder
  • Written exposure therapy

ASJC Scopus subject areas

  • Pharmacology

Cite this

@article{63d689f0102440be95ff7aec2b0c2bfc,
title = "Study design comparing written exposure therapy to cognitive processing therapy for PTSD among military service members: A noninferiority trial",
abstract = "Although there are a number of effective treatments for posttraumatic stress disorder (PTSD), there is a need to develop more efficient evidence-based PTSD treatments to address barriers to seeking and receiving treatment. Written exposure therapy (WET) is a potential alternative that is a 5-session treatment without any between-session assignments. WET has demonstrated efficacy, and low treatment dropout rates. However, prior studies with WET have primarily focused on civilian samples. Identifying efficient PTSD treatments for military service members is critical given the high prevalence of PTSD in this population. The current ongoing randomized clinical trial builds upon the existing literature by investigating whether WET is equally efficacious as Cognitive Processing Therapy (CPT) in a sample of 150 active duty military service members diagnosed with PTSD who are randomly assigned to either WET (n = 75) or CPT (n = 75). Participants are assessed at baseline and 10, 20, and 30 weeks after the first treatment session. The primary outcome measure is PTSD symptom severity assessed with the Clinician Administered PTSD Scale for DSM-5. Given the prevalence of PTSD and the aforementioned limitations of currently available first-line PTSD treatments, the identification of a brief, efficacious treatment that is associated with reduced patient dropout would represent a significant public health development.",
keywords = "Clinical trial, Cognitive behavioral therapy, Posttraumatic stress disorder, Written exposure therapy",
author = "{For the STRONG STAR Consortium} and Sloan, {Denise M.} and Marx, {Brian P.} and Resick, {Patricia A.} and Stacey Young-McCaughan and Dondanville, {Katherine A.} and Jim Mintz and Litz, {Brett T.} and Peterson, {Alan L.}",
year = "2020",
month = "3",
doi = "10.1016/j.conctc.2019.100507",
language = "English (US)",
volume = "17",
journal = "Contemporary Clinical Trials Communications",
issn = "2451-8654",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Study design comparing written exposure therapy to cognitive processing therapy for PTSD among military service members

T2 - A noninferiority trial

AU - For the STRONG STAR Consortium

AU - Sloan, Denise M.

AU - Marx, Brian P.

AU - Resick, Patricia A.

AU - Young-McCaughan, Stacey

AU - Dondanville, Katherine A.

AU - Mintz, Jim

AU - Litz, Brett T.

AU - Peterson, Alan L.

PY - 2020/3

Y1 - 2020/3

N2 - Although there are a number of effective treatments for posttraumatic stress disorder (PTSD), there is a need to develop more efficient evidence-based PTSD treatments to address barriers to seeking and receiving treatment. Written exposure therapy (WET) is a potential alternative that is a 5-session treatment without any between-session assignments. WET has demonstrated efficacy, and low treatment dropout rates. However, prior studies with WET have primarily focused on civilian samples. Identifying efficient PTSD treatments for military service members is critical given the high prevalence of PTSD in this population. The current ongoing randomized clinical trial builds upon the existing literature by investigating whether WET is equally efficacious as Cognitive Processing Therapy (CPT) in a sample of 150 active duty military service members diagnosed with PTSD who are randomly assigned to either WET (n = 75) or CPT (n = 75). Participants are assessed at baseline and 10, 20, and 30 weeks after the first treatment session. The primary outcome measure is PTSD symptom severity assessed with the Clinician Administered PTSD Scale for DSM-5. Given the prevalence of PTSD and the aforementioned limitations of currently available first-line PTSD treatments, the identification of a brief, efficacious treatment that is associated with reduced patient dropout would represent a significant public health development.

AB - Although there are a number of effective treatments for posttraumatic stress disorder (PTSD), there is a need to develop more efficient evidence-based PTSD treatments to address barriers to seeking and receiving treatment. Written exposure therapy (WET) is a potential alternative that is a 5-session treatment without any between-session assignments. WET has demonstrated efficacy, and low treatment dropout rates. However, prior studies with WET have primarily focused on civilian samples. Identifying efficient PTSD treatments for military service members is critical given the high prevalence of PTSD in this population. The current ongoing randomized clinical trial builds upon the existing literature by investigating whether WET is equally efficacious as Cognitive Processing Therapy (CPT) in a sample of 150 active duty military service members diagnosed with PTSD who are randomly assigned to either WET (n = 75) or CPT (n = 75). Participants are assessed at baseline and 10, 20, and 30 weeks after the first treatment session. The primary outcome measure is PTSD symptom severity assessed with the Clinician Administered PTSD Scale for DSM-5. Given the prevalence of PTSD and the aforementioned limitations of currently available first-line PTSD treatments, the identification of a brief, efficacious treatment that is associated with reduced patient dropout would represent a significant public health development.

KW - Clinical trial

KW - Cognitive behavioral therapy

KW - Posttraumatic stress disorder

KW - Written exposure therapy

UR - http://www.scopus.com/inward/record.url?scp=85076246239&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076246239&partnerID=8YFLogxK

U2 - 10.1016/j.conctc.2019.100507

DO - 10.1016/j.conctc.2019.100507

M3 - Article

AN - SCOPUS:85076246239

VL - 17

JO - Contemporary Clinical Trials Communications

JF - Contemporary Clinical Trials Communications

SN - 2451-8654

M1 - 100507

ER -